Suspected adverse events following immunization against SARS-CoV2 in a university hospital in 2021: Observational study.

Dolores RodríguezPilar OrdoñezRoser LlopSebastián VidelaAurema OteroThiago CarnavalVioleta PoltorakMiguel Moya-GuerolaCristina Masuet-AumatellSoledad RodriguezPilar Hereu

Published in: Medicine (2022)

The majority of suspected ADR reported were described in the summary of product characteristics (SmPC). Professionals with a history of COVID-19 reported more suspected ADR after the first dose than did those without a history.

Keyphrases

sars cov
pulmonary embolism
coronavirus disease
adverse drug
respiratory syndrome coronavirus
electronic health record